Companies: 10,795·Total market cap: $144.5T
ContraFect Corporation

ContraFect Corporation

CFRXQOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$107
P/E Ratio
52W High$0.0005
52W Low$0.00001

ContraFect Corporation (CFRXQ) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

cfrxq · pe ratio · data through Dec 31, 2022

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for ContraFect Corporation (CFRXQ) measures how much investors pay for each dollar of the company's trailing earnings. CFRXQ's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$124.97.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2022-12-31

Forward P/E
N/A
FY2026 est. EPS $-2.14
Based on 1 analyst
EPS (TTM)
-$124.97
TTM · diluted EPS
PEG Ratio
-0.00
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · ContraFect Corporation SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-08

PE Ratio History

2016 – 2022 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Biotechnology · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
ContraFect Corporation
ContraFect CorporationYou
CFRXQ
$0MN/A-$124.97
Adynxx, Inc.
Adynxx, Inc.
ADYX
$0MN/A-$10.26
BIMI International Medical Inc.
BIMI International Medical Inc.
BIMI
$0MN/A-$8.40
DMK Pharmaceuticals Corporation
DMK Pharmaceuticals Corporation
DMKPQ
$0MN/A-$12.37
eFFECTOR Therapeutics, Inc.
eFFECTOR Therapeutics, Inc.
EFTR
$0MN/A-$16.37
Grupo International Inc.
Grupo International Inc.
GRPI
$0MN/A-$0.01
IMV Inc.
IMV Inc.
IMVIF
$0MN/A-$4.37

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 7 of 7 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2022-12-31Latest
FY2022
$-124.97
2021-12-31
FY2021
$-44.12
2020-12-31
FY2020
$-98.95
2019-12-31
FY2019
$-123.57
2018-12-31
FY2018
$-396.35
2017-12-31
FY2017
$-223.29
2016-12-31
FY2016
$-680.72

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for ContraFect Corporation (CFRXQ) measures how much investors pay for each dollar of the company's trailing earnings. CFRXQ's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$124.97.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.00 ÷ -$124.97 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

CFRXQ pe ratio · 6 questions

CFRXQ's current PE ratio is N/A as of 2026-06-08, based on a stock price of $0.00 and TTM EPS of -$124.97. Data sourced from Financial Modeling Prep via CFRXQ's SEC 10-K and 10-Q filings.

CFRXQ PE ratioWhat is CFRXQ PE ratioCurrent PE ratio of CFRXQCFRXQ PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · ContraFect Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08